CASE Op-Ed – Townhall: Conservatives Should Not Surrender on Sugar
October 6, 2022 Winston Churchill’s quote imploring the forces of freedom to “never give in” has endured for more...
CASE Op-Ed – InsideSources: It’s Time to Tame the Big Tech Outlaws
June 21, 2022 The enduring image of the old American west, as propagated into our consciousness through film and...
Misguided “Buy American” Mandates Risk Catastrophic Consequences
June 22, 2020 As countries across the globe slowly begin the recovery from COVID-19,while also bracing for a possible second...
CASE Op-Ed – Morning Consult: Ireland’s Turn to Tax Uncertainty a Lesson — and Opportunity — for the United States
Matthew Kandrach – President, CASE November 21, 2019 The Celtic Tiger is losing its roar. Recent Irish Revenue reversals...
Europe’s Surrender on Sugar Was a Bad Deal America Should Not Repeat
President Trump’s approach toward trade negotiations from day one has emphasized one theme above all others; the “bad deals” made...
CASE Op-Ed – Daily Caller: America Must Not Repeat the Great European Sugar Disaster
Gerard Scimeca – Chairman, CASE September 10, 2018 – https://bit.ly/2oUjzg2 It’s extremely doubtful that somewhere there is a room full...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/